After a review of evidence, the UK Health Security Agency (HSA) said today that it no longer classifies clade 1a and 1b mpox ...
Canada has an opportunity to prevent sustained Clade I mpox transmission, but only if decisive action is taken now.
NIH-sponsored trial data offers further evidence to help inform mpox treatment decisions.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback